Octrooien

Filter Op Archive
Clear all
Blijf op de hoogte van ons nieuws
  • The European Unitary Patent System looks to be back on track again

    Jul 15, 2021 | Tags: Octrooien , IP Insight

  • Using disclosures to your advantage

    Jul 14, 2021 | Tags: Octrooien , IP Insight

  • NFTs – a slam dunk or a sticky wicket for brand owners?

    Jul 6, 2021 | Tags: Octrooien , Merken , IP Insight

  • Disclosures

    Jul 5, 2021 | Tags: Octrooien , IP Insight

  • Covid vaccine patent waivers – the opinion of our vaccine IP specialist

    May 6, 2021 | Tags: Octrooien , Biosciences , IP Insight

  • Where to Obtain Patent Protection?

    Mar 9, 2021 | Tags: Octrooien , IP Insight

  • Chemists are in the driving seat of electric vehicle development

    Feb 25, 2021 | Tags: Octrooien , Energy and environment , Battery technology

  • Freedom to Operate – What does it mean and a look at some different approaches

    Jan 25, 2021 | Tags: Octrooien , IP Insight

  • Medical inventions – a European perspective

    Jan 19, 2021 | Tags: Octrooien , Biosciences , IP Insight

  • Expediting Patent Prosecution – Use of International Examination

    Nov 24, 2020 | Tags: Octrooien , IP Insight

  • Videoconference Hearings at the EPO – A Game-Changing Announcement from the EPO

    Nov 11, 2020 | Tags: Octrooien , IP Insight

  • The Unitary Patent and Unified Patent Court system – an update

    Jul 21, 2020 | Tags: Octrooien , IP Insight

  • No SPCs for new therapeutic applications of old drugs – CJEU overturns Neurim

    Jul 16, 2020 | Tags: Octrooien , Biosciences , IP Insight

  • Money for old dope

    Jul 15, 2020 | Tags: Octrooien , IP Insight

  • “No Patents On Peppers”… or any plants or animals exclusively obtained by means of an essentially biological process

    May 27, 2020 | Tags: Octrooien , Biosciences , Food and drink , IP Insight

  • Mobile apps at the forefront of the Covid-19 fight

    May 13, 2020 | Tags: Octrooien , Merken , Biosciences , Modellen , Software